
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.

PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
WELL Health Reports Strong Organic Growth, Major Advances in Clinic Digitization, and Rapid Progress on New Primary Care Patient Openings
LSL PHARMA GROUP REPORTS FOURTH CONSECUTIVE RECORD QUARTERLY REVENUES AND Q3 2025 FINANCIAL RESULTS
BioNxt Secures Final Patent Grant from the Eurasian Patent Organization for Sublingual Cladribine Platform
Surenano Science signs LOI to acquire GlucaPharm
Rocket Doctor firms up deal to acquire Alea Health
Extendicare to Expand its Home Health Care Business by Acquiring CBI Home Health for $570 Million in Cash Consideration
Medicure Reports Financial Results for Quarter Ended September 30, 2025
SureNano Announces Non-Binding Letter of Intent to Negotiate Proposed Transaction of GlucaPharm Inc. for GLP-1 Drug Development
Arch Biopartners Closes Non-Brokered Private Placement
NervGen Pharma Announces Closing of US$10 Million Non-Brokered Private Placement to Support Anticipated Nasdaq Listing and Advance NVG-291 Development
BioVaxys Technology Corp. Closes Listed Issuer Financing Exemption (LIFE) Private Placement
Defence working to supply Accum to ADC companies
ROCKET DOCTOR AI INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE ALEA HEALTH HOLDINGS LTD.
Fennec Pharmaceuticals Announces Completion Of Full Debt Redemption